These results conclusively indicated that NO must represent an initiator of RA-like arthritis, mainly responsible for synovial hyperplasia, so NO-initiated synovial lesions might not be reversible by any NOS inhibitors. This evidence concerns the gene NOS2 and rheumatoid arthritis.